NEW YORK, August 11, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding Tesla Motors Inc. (NASDAQ: TSLA), The Procter & Gamble Company (NYSE: PG), PepsiCo, Inc. (NYSE: PEP), Nu Skin Enterprises, Inc. (NYSE: NUS) and Ralph Lauren Corp. (NYSE: RL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5624-100free.
--
Tesla Motors Inc. Research Reports
On July 31, 2014, Tesla Motors Inc. (Tesla) reported Q2 2014 total revenues of $769.3 million, up 89.9% YoY. In Q2 2014, the Company's Model S deliveries reached a new record of 7,579 vehicles. According to a consensus estimate from Thomson Reuters, Wall Street analysts expected the Company to report Q2 2014 EPS of $0.04 (excluding items) on revenues of $811 million. The Company's Q2 2014 net loss came in at $61.9 million or $0.50 diluted per share, compared to net loss of $30.5 million or $0.26 per share in Q2 2013. The Company's H1 2014 total revenues improved 43.7% YoY to $1.4 billion, while net loss stood at $111.7 million, compared to net loss of $19.3 million in H1 2013. For Q3 2014, the Company expects to produce 9,000 cars and deliver 7,800 Model S vehicles, while for full-year 2014, the Company expects to deliver more than 35,000 Model S vehicles. The full research reports on Tesla are available to download free of charge at:
http://www.analystsreview.com/Aug-11-2014/TSLA/report.pdf
--
The Procter & Gamble Company Research Reports
On August 5, 2014, The Procter & Gamble Company (P&G) issued a press release in correction to a release issued on August 4, 2014 due to a change in the list of available retail stores. On July 4, 2014, the Company announced the launch of a new Charmin toilet paper- Charmin Plus the Scent of Chamomile. The Company stated that each roll of toilet paper has the scent of chamomile added to the tube to create a better bathroom experience. In addition, Charmin is partnering with Ana Patricia Gonzales, host of Despierta América! on Univision to introduce the new Charmin plus the scent of Chamomile. Further, the brand will be available at the Festival de la Villita in Chicago in September, 2014. The Company stated that Charmin plus with the scent of Chamomile is available in retail stores across the U.S. including Target, Kroger, Walmart, HEB, Safeway and Walgreens. The full research reports on P&G are available to download free of charge at:
http://www.analystsreview.com/Aug-11-2014/PG/report.pdf
--
PepsiCo, Inc. Research Reports
On August 6, 2014, PepsiCo, Inc. (PepsiCo) reported that the Company, along with its partner Feed the Children and other corporate partners, extended its help to Buffalo families in need by providing them food, essentials and Avon products. PepsiCo informed that eight hundred families visited West Buffalo Charter School and took home boxes containing food and basic essentials that filled two tractor-trailers. Further, the Company, together with Feed the Children, Tops Markets, Buffalo Dream Center, and Avon provided enough supplemental food and essentials to Buffalo families to last up to one week. The full research reports on PepsiCo are available to download free of charge at:
http://www.analystsreview.com/Aug-11-2014/PEP/report.pdf
--
Nu Skin Enterprises, Inc. Research Reports
On August 6, 2014, Nu Skin Enterprises, Inc. (Nu Skin) reported 3.2% YoY decline in its Q2 2014 total revenue to $650.0 million, while operating income declined 52.2% YoY to $54.7 million. The Company's Q2 2014 net income came in at $19.5 million or $0.32 per diluted share, compared to $74.4 million or $1.22 per diluted share in Q2 2013. Seven analysts polled by Thomson Reuters expected the Company to report Q2 2014 EPS of $1.27 (excluding special items) and revenues of $709.0 million. The Company's H1 2014 total revenue improved 8.9% YoY to $1.3 billion, while net income declined 42.2% YoY to $74.4 million. For Q3 2014, the Company expects revenue in the range of $620 -$640 million and EPS between $0.90 and $0.95, while for Q4 2014, the Company expects revenue between $650-$675 million and EPS in the range of $1.00 - $1.05. The full research reports on Nu Skin are available to download free of charge at:
http://www.analystsreview.com/Aug-11-2014/NUS/report.pdf
--
Ralph Lauren Corp. Research Reports
On August 6, 2014, Ralph Lauren Corp. (Ralph Lauren) released its Q1 FY 2014 financial results (period ended June 28, 2014). The Company reported Q1 FY 2014 net revenues of $1.7 billion, up 3.3% YoY, led by strong retail segment sales growth and double-digit expansion in international markets. The Company's Q1 FY 2014 net income stood at $162 million or $1.80 per diluted share, compared to net income of $181 million or $1.94 per diluted share in Q1 FY 2013. Analysts at Zacks expected the Company to post Q1 FY 2014 EPS of $1.75 and revenues of $1.73 billion. For full-year FY 2015, the Company expects consolidated revenue growth in the range of 6-8%. The full research reports on Ralph Lauren are available to download free of charge at:
http://www.analystsreview.com/Aug-11-2014/RL/report.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
